EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Small molecule inhibitor of orphan GPCR dimerization improves host defense and blood pressure control in mice

Jeonghyeon Kwon, Margherita Persechino, Jingchen Shao, Jamal Shamsara, Birgit Spitznagel, Isabelle Salwig, Miloslav Sanda, Stefan Offermanns, Peter Kolb, Nina Wettschureck

Journal of Clinical Investigation · 03.08.2026 · 136 (15)

DOI: 10.1172/jci203162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 03.08.2026. Verfasst von Jeonghyeon Kwon und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany. Hauptthemen laut MEDLINE: Blood Pressure, Receptors, G-Protein-Coupled, Protein Multimerization, Peritonitis. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LOEWE-GLUE initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Orphan GPCRs of the GPRC5 family regulate macrophage activity and vascular contractility by dimerizing with other GPCRs, but pharmacological modulation of this process has not been explored. We previously identified the dimerization interface of receptor GPRC5B and show here that both its mutation and inhibition by a decoy peptide disturbed the interaction with the prostaglandin E2 receptor EP2 in macrophages, resulting in reduced EP2 signaling, enhanced migration and phagocytosis, and protection from bacterial peritonitis in mice. Furthermore, we show that a similar interface exists in related receptor GPRC5C, and, the same as in GPRC5B, mutation or inhibition by decoy peptide improved host defense. Through a virtual docking screen, we identified a small molecule inhibitor of both GPRC5B and GPRC5C dimerization, K303MP20, and showed that it reduced EP2 signaling, enhanced macrophage activity, and improved host defense in bacterial peritonitis and influenza A infection. Interestingly, K303MP20 not only blocked dimerization between GPRC5B/C and EP2, but also with prostacyclin receptor IP and angiotensin II receptor AT1, resulting in reduced AT1-dependent contraction and enhanced IP-dependent relaxation in human and murine smooth muscle cells. In vivo, K303MP20 did not affect basal blood pressure, but protected mice from angiotensin II–induced hypertension. Taken together, inhibition of orphan GPCR dimerization by small molecules is feasible and improves infection control and arterial hypertension. Pharmacological blockade of GPRC5B/GPRC5C dimerization improves infection control and prevents arterial hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PressureReceptors, G-Protein-CoupledProtein MultimerizationPeritonitisAnimalsMiceHumansMacrophagesReceptors, Prostaglandin E, EP2 SubtypeSignal TransductionMaleReceptors, Epoprostenol

Stichwörter der Autor:innen

G protein-coupled receptorsImmunologyPharmacologySignal transductionVascular biology

Substanzen

Receptors, G-Protein-CoupledReceptors, Prostaglandin E, EP2 SubtypePtgir protein, mouseReceptors, Epoprostenol

Autor:innen und Institutionen

  • Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
  • Department of Pharmaceutical Chemistry, Philipps-Universität Marburg, Marburg, Germany.
  • Department of Cardiac Development and Remodeling and.
  • Biomolecular Mass Spectrometry, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
  • German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Frankfurt am Main, Germany.
  • Cardiopulmonary Institute (CPI), Goethe University, Frankfurt am Main, Germany.

Förderung

  • LOEWE-GLUE initiative

Zitieren

APA

Kwon, J., Persechino, M., Shao, J., Shamsara, J., Spitznagel, B., Salwig, I., Sanda, M., Offermanns, S., Kolb, P., & Wettschureck, N. (2026). Small molecule inhibitor of orphan GPCR dimerization improves host defense and blood pressure control in mice. Journal of Clinical Investigation, 136(15). https://doi.org/10.1172/jci203162

Vancouver

Kwon J, Persechino M, Shao J, Shamsara J, Spitznagel B, Salwig I, et al. Small molecule inhibitor of orphan GPCR dimerization improves host defense and blood pressure control in mice. Journal of Clinical Investigation. 2026;136(15). doi:10.1172/jci203162

BibTeX
@article{Kwon2026,
  author = {Kwon, Jeonghyeon and Persechino, Margherita and Shao, Jingchen and Shamsara, Jamal and Spitznagel, Birgit and Salwig, Isabelle and Sanda, Miloslav and Offermanns, Stefan and Kolb, Peter and Wettschureck, Nina},
  title = {Small molecule inhibitor of orphan GPCR dimerization improves host defense and blood pressure control in mice},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {15},
  doi = {10.1172/jci203162}
}
Kostenlos starten →